603168 fundamentals
An in-depth look to ZHEJIANG SHAPUAISI PHARMACEUTICAL operating, investing, and financing activities
603168 free cash flow for Q1 24 is -37.44 M CNY. For 2023, 603168 free cash flow was -178.3 M CNY and operating cash flow was 41.49 M CNY.
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: CNY
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
TTM